CD80 expression on monocytes in HIV-infected patients

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 15, Issue 4, 1997, Pages 264-268

  Low P ^a   Weber, C ^a   Harrer, E ^a   Rohwer, P ^a   Kalden, J R ^a   Harrer, T ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

AIDS; CD80; HIV; Monocytes

Indexed keywords

ALPHA INTERFERON; B7 ANTIGEN; DIDANOSINE; STAVUDINE; ZIDOVUDINE;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; CLINICAL ARTICLE; FEMALE; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREGULATION; MALE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0030747088     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199708010-00003     Document Type: Article

References (29)

1. Ebretson J, Zupancic M, Ribas JL, et al. Massive covert infection of helper T lymphocytes and macrophages by HIV during incubation period of AIDS. Nature 1993;362:359-62.
2. Pantaleo G, Graziosi C, Demarest JF, et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993;362:355-8.
3. Murray HW, Hillman JK, Rubin BY, et al. Patients at risk for AIDS-related opportunistic infection: clinical manifestations and impaired gamma-interferon production. N Engl J Med 1985;313: 1504-10.
4. Freedman AS, Freeman GJ, Rhynhart K, Nadler LM. Selective induction of B7/BB-1 on interferon-gamma stimulated monocytes: a potential mechanism for amplification of T cell activation through the CD28 pathway. Cell Immunol 1991;137:429-37.
5. Harrer T, Wolf B, Kersten W, Schwarz W, Bergner D, Kalden JR. HIV-1-antigenemia and T-cell-activation in HIV-infected patients. Klin Wochenschr 1990;68:864-8.
6. Westendorp MO, Frank R, Ochsenbauer C, et al. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 1995;375:497-500.
7. Mueller DL, Jenkins MK, Schwartz RH. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu Rev Immunol 1989;7:445-80.
8. Linsley PS, Ledbetter JA. The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 1991;11:191-212.
9. + CD28- cell population in the blood and lung of HIV-positive patients. JAIDS 1993;6:1194-1204.
10. + T lymphocyte-mediated lysis of Chlamydia-infected L cells using an endogenous antigen pathway. J Immunol 1994;153:4588-95.
11. Azuma A, Cayabyab M, Buck D, Phillips JH, Lanier LL. CD28 interaction with B7 costimulates primary allgeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes. J Exp Med 1992;175:353-60.
12. Harding FA, McArthur JG, Gross JA, Raulet DH, Allison JP. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 1992;356:607.
13. Schuitemaker H, Kootstra NA, De Goede RE, De Wolf F, Miedema F, Termette M. Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture. J Virol 1991;65:356-63.
14. Prince HE, Moody DJ, Shubin BI, Fahey JL. Defective monocyte function in acquired immune deficiency syndrome (AIDS): evidence from a monocyte-dependent T-cell proliferative system. J Clin Immunol 1985;5:21-5.
15. Braun DP, Harris JE. Abnormal monocytes function in patients with Kaposi's sarcoma. Cancer 1986;57:1501-6.
16. Rich EA, Toossi Z, Fujiwara H, Hanigosky R, Lederman MM, Ellner JJ. Defective accessory function of monocytes in human immunodeficiency virus-related disease syndromes. J Lab Clin Med 1988;112:174-81.
17. Chirmule N, McCloskey TW, Hu R, Kalyanarman VS, Pahwa S. HIV gp120 inhibits T cell activation by interfering with expression of costimulatory molecules CD40 ligand and CD80 (B71). J Immunol 1995;155:917-24.
18. Jenkins MK, Tylor PS, Norton SD, Urdahl KB. CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells. J Immunol 1991;147:2461.
19. Meyaard L, Kuiper H, Otto SA, Wolthers KC, van Lier RAW, Miedema F. Evidence for intact costimulation via CD28 and CD27 molecules in hyporesponsive T cells form human immunodeficiency virus-infected individuals. Eur J Immunol 1995;25:232-7.
20. Takashi Y, Holly RD, Clark EA. B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lins, and Burkitt's lymphomas. J Immunol 1982;128: 823-7.
21. Hathcock K, Laszlo G, Pucillo C, Linsley P, Hodes RJ. Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J Exp Med 1994;180:631-40.
22. + T cells from human immunodeficiency virus type 1-infected donors. Proc Natl Acad Sci USA 1993;90: 11094-8.
23. Pinchuk LM, Polacino PS, Agy MB, Klaus SJ, Clark EA. The role of CD40 and CD80 accessory cell molecules in dendritic cell-dependent HIV-1 infection. Immunity 1994;1:317-25.
24. Kaye PM, Rogers NJ, Curry AJ, Scott JC. Deficient expression of co-stimulatory molecules on Leishmania-infected macrophages. Eur J Immunol 1994;24:2850-4.
25. Buhl R, Jaffe HA, Kenneth JH, et al. Activation of alveolar macrophages in asymptomatic HIV-infected individuals. J Immunol 1993;150:1019-28.
26. Twigg HL III, Iwamoto GK, Soliman DM. Role of cytokines in alveolar macrophage accessory cell function in HIV-infected individuals. J Immunol 1992;149:1462-9.
27. + cells in the lung. Am J Respir Cell Mol Biol 1989;1:391-400.
28. Harrer T, Messing K, Bienzle U, Meyer E, Giedl J, Kalden JR. Manifestation von AIDS in HIV-infizierten homosexuellen Männern mit Lymphadenopathie-Syndrom (LAS). Klin Wochenschr 1989;67:936-9.
29. Kobayashi S, Hamamoto Y, Kobayashi N, Yamamoto N. Serum level of TNF alpha in HIV-infected individuals [letter]. AIDS 1990;4:169-70.